You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 3, July 21, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey

Michael P. Stern, MD; Judith K. Patterson, PhD; Steven M. Haffner, MD; Helen P. Hazuda, PhD; Braxton D. Mitchell, PhD

JAMA. 1989;262(3):360-364.


Abstract

Cardiovascular disease is the leading cause of morbidity, disability, and death among patients with type II (non—insulin-dependent) diabetes mellitus. Moreover, hyperlipidemia is also common among these patients. Despite this, there are virtually no data regarding the level of awareness and treatment of hyperlipidemia among diabetic subjects at the community level. We therefore examined 374 Mexican-Americans and 86 non-Hispanic whites with type II diabetes identified in an epidemiologic survey that involved 3279 Mexican-Americans and 1847 non-Hispanic whites who resided in San Antonio, Tex. More than 40% of the diabetic subjects were hyperlipidemic according to the criteria of the National Cholesterol Education Program, and an additional 23% had hypertriglyceridemia and/or low levels of high-density lipoprotein cholesterol. By contrast, less than one fourth of the nondiabetic subjects were hyperlipidemic. Only approximately 25% of non-Hispanic whites with diabetes were aware of their hyperlipidemia, and less than 10% were receiving treatment. Awareness and treatment were even less frequent among Mexican-Americans with diabetes. Community physicians should be encouraged to give early attention to the management of lipid disorders in their diabetic patients.

(JAMA. 1989;262:360-364)



Author Affiliations

From the Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center, San Antonio.


Footnotes

Reprint requests to the Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78284 (Dr Stern).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
Abdul-Ghani et al.
Diabetes Care 2008;31:1650-1655.
ABSTRACT | FULL TEXT  

What Is the Best Predictor of Future Type 2 Diabetes?
Abdul-Ghani et al.
Diabetes Care 2007;30:1544-1548.
ABSTRACT | FULL TEXT  

Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose
Abdul-Ghani et al.
Diabetes Care 2006;29:1613-1618.
ABSTRACT | FULL TEXT  

Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance
Meigs et al.
Diabetes Care 2004;27:1417-1426.
ABSTRACT | FULL TEXT  

Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies
Meigs et al.
Diabetes 2003;52:2160-2167.
ABSTRACT | FULL TEXT  

Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT | FULL TEXT  

Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
Stern et al.
ANN INTERN MED 2002;136:575-581.
ABSTRACT | FULL TEXT  

Factors of Insulin Resistance Syndrome-Related Phenotypes Are Linked to Genetic Locations on Chromosomes 6 and 7 in Nondiabetic Mexican-Americans
Arya et al.
Diabetes 2002;51:841-847.
ABSTRACT | FULL TEXT  

Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans.
Stern et al.
Genome Res 1996;6:724-734.
ABSTRACT  

Efforts to Improve Compliance With the National Cholesterol Education Program Guidelines: Results of a Randomized Controlled Trial
Headrick et al.
Arch Intern Med 1992;152:2490-2496.
ABSTRACT  

Nicotinic Acid as Therapy for Dyslipidemia in Non--Insulin-Dependent Diabetes Mellitus
Garg and Grundy
JAMA 1990;264:723-726.
ABSTRACT  

Systeme International Units and Familiar Formulas: The Case of Lipids
Giral et al.
JAMA 1990;263:2302-2302.
ABSTRACT  

From an Excess of Fat, Diabetics Die
Steiner
JAMA 1989;262:398-399.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.